Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Herceptin|DRUG: NeuVax vaccine|DRUG: GM-CSF
Sponsor: George E. Peoples
Collaborators: Genentech, Inc.|Sellas Life Sciences Group